Clinical Trials for CG Pharmaceuticals

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: CG Pharmaceuticals

Clinical Trials (1)

NCT05249101
A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma
PHASE1/PHASE2Recruiting
70 participants
Started: Aug 15, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor16 locations